Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Mv, Cherkasova"'
Autor:
MS Sergeeva, BS Belov, GM Tarasova, EN Alexandrova, AA Novikov, MV Cherkasova, DE Karateev, EL Luchikhina, YV Muravyev, DV Buhanova
Publikováno v:
Poster Presentations.
Autor:
Tm, Reshetniak, Seredavkina V, Es, Mach, En, Aleksandrova, Alexander Novikov, Mv, Cherkasova, El, Nasonov
Publikováno v:
Europe PubMed Central
To evaluate intima-media complex (IMC) thickness in patients with antiphospholipid syndrome in terms of clinical-laboratory manifestations and thrombosis risk factors.The trial included 206 patients (57 males and 149 females, age 16-59, mean age 35.9
Autor:
Alexander Novikov, En, Aleksandrova, Karateev DE, El, Luchikhina, Nv, Demidova, Mv, Cherkasova, Ln, Denisov, El, Nasonov
Publikováno v:
Europe PubMed Central
A hundred and two patients (18 males, 84 females; mean age, 50.3 +/- 12.3 years) diagnosed as having early rheumatoid arthritis (RA) were examined. A control group consisted of 189 patients with various rheumatic diseases and 30 healthy donors. The s
Autor:
Alexander Novikov, Mv, Cherkasova, En, Aleksandrova, Tv, Popkova, El, Luchikhina, Ns, Rytikova, El, Nasonov
Publikováno v:
Europe PubMed Central
The hyper production of large specter of autoantibodies, primarily rheumatoid factors and antibodies to citrullinized proteins, is a characteristic sign of rheumatoid arthritis. The detection of these antibodies plays an important role in diagnosing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5eab1f0b12c49044b330ecc2a72c761e
http://europepmc.org/abstract/med/23265058
http://europepmc.org/abstract/med/23265058
Publikováno v:
Europe PubMed Central
The article deals with results of study targeted to reveal laboratory biomarkers which can be useful in prognosis of effectiveness of rituximab therapy under rheumatoid arthritis. The sampling consisted of 34 patients with rheumatoid arthritis (31 wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b7306a566577859908ad4b90367de6d1
http://europepmc.org/abstract/med/25080789
http://europepmc.org/abstract/med/25080789
Publikováno v:
Europe PubMed Central
To evaluate the impact of tocilizumab (TCZ) therapy on the level of matrix metalloproteinase-3 (MMP-3) 4, 24, and 48 weeks after treatment initiation in relation to the clinical efficiency of TCZ therapy by the Disease Activity Score (DAS28), the Cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9e95f88c127e3b34420b17f3ecb67986
http://europepmc.org/abstract/med/23819335
http://europepmc.org/abstract/med/23819335
Autor:
Cherkasova MV; Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada; Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: mariya.cherkasova@mail.wvu.edu., Clark L; Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada; Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada., Barton JJS; Department of Medicine, Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada; Department of Ophthalmology, University of British Columbia, Vancouver, British Columbia, Canada., Stoessl AJ; Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine, Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada., Winstanley CA; Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada; Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: cwinstanley@psych.ubc.ca.
Publikováno v:
Behavioural brain research [Behav Brain Res] 2024 Mar 12; Vol. 461, pp. 114865. Date of Electronic Publication: 2024 Jan 14.
Autor:
Avdeeva AS; Nasonova Research Institute of Rheumatology, Moscow, Russia. 9056249400@mail.ru., Cherkasova MV; Nasonova Research Institute of Rheumatology, Moscow, Russia., Nasonov EL; Nasonova Research Institute of Rheumatology, Moscow, Russia.; Department of Rheumatology, Institute of Professional Education, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Publikováno v:
Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2023 Dec; Vol. 513 (1), pp. 361. Date of Electronic Publication: 2024 Jan 24.
Autor:
Reshetnyak TM; Nasonova Research Institute of Rheumatology, Moscow, Russia. t_reshetnyak@yahoo.com.; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia. t_reshetnyak@yahoo.com., Cheldieva FA; Nasonova Research Institute of Rheumatology, Moscow, Russia.; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia., Cherkasova MV; Nasonova Research Institute of Rheumatology, Moscow, Russia., Glukhova SI; Nasonova Research Institute of Rheumatology, Moscow, Russia., Lila AM; Nasonova Research Institute of Rheumatology, Moscow, Russia.; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Moscow, Russia., Nasonov EL; Nasonova Research Institute of Rheumatology, Moscow, Russia.; Sechenov First Moscow State Medical University of the Ministry of Health Care of Russian Federation (Sechenov University), Moscow, Russia.
Publikováno v:
Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2023 Dec; Vol. 513 (1), pp. 358. Date of Electronic Publication: 2024 Jan 24.
Autor:
Ananyeva LP; Nasonova Research Institute of Rheumatology, Moscow, Russia. lpana@yandex.ru., Garzanova LA; Nasonova Research Institute of Rheumatology, Moscow, Russia., Koneva OA; Nasonova Research Institute of Rheumatology, Moscow, Russia., Starovoytova MN; Nasonova Research Institute of Rheumatology, Moscow, Russia., Desinova OV; Nasonova Research Institute of Rheumatology, Moscow, Russia., Ovsyannikova OB; Nasonova Research Institute of Rheumatology, Moscow, Russia., Shayakhmetova RU; Nasonova Research Institute of Rheumatology, Moscow, Russia., Cherkasova MV; Nasonova Research Institute of Rheumatology, Moscow, Russia., Aleksankin AP; Nasonova Research Institute of Rheumatology, Moscow, Russia., Nasonov EL; Nasonova Research Institute of Rheumatology, Moscow, Russia.; Sechenov First Moscow State Medical University of the Ministry of Health Care of the Russian Federation (Sechenov University), Moscow, Russia.
Publikováno v:
Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2023 Dec; Vol. 513 (1), pp. 362. Date of Electronic Publication: 2024 Jan 24.